STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway

被引：0
|
作者：
Yichao Zhang
Junhui Xu
Zhendong Qiu
Yongjun Guan
XiaoYi Zhang
Xin Zhang
Dongqi Chai
Chen Chen
Qinyong Hu
Weixing Wang
机构：
[1] Renmin Hospital of Wuhan University,Department of General Surgery
[2] Renmin Hospital of Wuhan University,Cancer Center
[3] ZhongNan Hospital of Wuhan University,Intensive Care Unit
来源：
Cancer Cell International | / 22卷
关键词：
STK25; STRN; HCC; Lipid metabolism; Cancer; Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway
    Zhang, Yichao
    Xu, Junhui
    Qiu, Zhendong
    Guan, Yongjun
    Zhang, XiaoYi
    Zhang, Xin
    Chai, Dongqi
    Chen, Chen
    Hu, Qinyong
    Wang, Weixing
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [2] Activation of YAP1 by STK25 contributes to the progression of hepatocellular carcinoma
    Jiang, Jiong
    Zheng, Ying
    Chen, Fenrong
    Dong, Lei
    Guo, Xiaoyan
    TISSUE & CELL, 2022, 76
  • [3] Exosomal miR-4800-3p Aggravates the Progression of Hepatocellular Carcinoma via Regulating the Hippo Signaling Pathway by Targeting STK25
    Lin, Haoming
    Peng, Jicai
    Zhu, Taifeng
    Xiong, Meihong
    Zhang, Rui
    Lei, Liming
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Antagonizing STK25 Signaling Suppresses the Development of Hepatocellular Carcinoma Through Targeting Metabolic, Inflammatory, and Pro-Oncogenic Pathways
    Kurhe, Yeshwant
    Caputo, Mara
    Cansby, Emmelie
    Xia, Ying
    Kumari, Sima
    Anand, Sumit Kumar
    Howell, Brian W.
    Marschall, Hanns-Ulrich
    Mahlapuu, Margit
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2022, 13 (02): : 405 - 423
  • [5] Ste20-like Kinase STK25: A Potential Target in Prevention and Therapy of NASH-Associated Hepatocellular Carcinoma?
    Kuehnel, Florian
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2022, 13 (02): : 676 - 677
  • [6] ACC1 Inhibition Enhances Treg Gvhd Treatment Efficacy through Regulation of Mitochondrial Fusion and Elongation
    McDonald-Hyman, Cameron
    Aguilar, Ethan G.
    Rhee, Stephanie Y.
    Mohamed, Fathima A.
    Compeer, Ewaldus
    Sparwassar, Timothy
    Dustin, Michael
    Blazar, Bruce R.
    BLOOD, 2023, 142
  • [7] STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway
    Zhang, Chengfei
    Wang, Xiaoming
    Fang, Dan
    Xu, Ping
    Mo, Xiao
    Hu, Chao
    Abdelatty, Alaa
    Wang, Mei
    Xu, Haojun
    Sun, Qi
    Zhou, Guoren
    She, Junjun
    Xia, Jinglin
    Hui, Kam Man
    Xia, Hongping
    THERANOSTICS, 2021, 11 (05): : 2108 - 2122
  • [8] Madecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARγ/AMPK/ACC1 pathway
    Xiaotian Xu
    Yuhui Wang
    Zhifeng Wei
    Wenhui Wei
    Peng Zhao
    Bei Tong
    Yufeng Xia
    Yue Dai
    Cell Death & Disease, 2017, 8 : e2723 - e2723
  • [9] Heme oxygenase-1 retards hepatocellular carcinoma progression through the microRNA pathway
    Zou, Chaoxia
    Zou, Chendan
    Cheng, Wanpeng
    Li, Qiang
    Han, Zhongjing
    Wang, Xiaona
    Jin, Jianfeng
    Zou, Jiaqi
    Liu, Zhiyan
    Zhou, Zhongqiu
    Zhao, Weiming
    Du, Zhimin
    ONCOLOGY REPORTS, 2016, 36 (05) : 2715 - 2722
  • [10] Madecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARγ/AMPK/ACC1 pathway
    Xu, Xiaotian
    Wang, Yuhui
    Wei, Zhifeng
    Wei, Wenhui
    Zhao, Peng
    Tong, Bei
    Xia, Yufeng
    Dai, Yue
    CELL DEATH & DISEASE, 2017, 8 : e2723 - e2723
12345